alexa Long-Term Results of Intralesional Triamcinolone Aceton
ISSN: 2167-0870

Journal of Clinical Trials
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Research Article

Long-Term Results of Intralesional Triamcinolone Acetonide Injections in Keloid Treatment

Kristiina Hietanen1*, Petri Välisuo2, Hannu Kuokkanen3 and Ilkka Kaartinen1

1Unit of Plastic Surgery, Department of Musculoskeletal Surgery and Diseases, Tampere University Hospital, Tampere, Finland

2Department of Electrical and Energy Engineering, University of Vaasa, Vaasa, Finland

3Department of Plastic Surgery, Helsinki University Hospital, Helsinki, Finland

*Corresponding Author:
Kristiina Hietanen
Unit of Plastic Surgery, Department of Musculoskeletal Surgery and Diseases
Tampere University Hospital, Tampere, Finland
E-mail: [email protected]

Received date: July 22, 2016; Accepted date: August 30, 2016; Published date: September 07, 2016

Citation: Hietanen K, Välisuo P, Kuokkanen H, Kaartinen I (2016) Long-Term Results of Intralesional Triamcinolone Acetonide Injections in Keloid Treatment. J Clin Trials 6:278. doi:10.4172/2167-0870.1000278

Copyright: © 2016 Hietanen K, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

 

Abstract

Background: Intralesional triamcinolone acetonide (TAC) injections are often used as the first alternative for treating keloid scarring. The long-term outcome of this treatment is unclear. Also, undesirable local side effects have been recognized in clinical work and literature but they have been labelled as harmless and rare. Methods: We documented the long-term outcome of intralesional TAC injections in the treatment of keloid scars in Tampere University Hospital. The main objectives were to investigate the remission rate and the occurrence of local side effects. We assessed 105 patients (46 women, 59 men) with 138 TAC treated keloid scars at the outpatient clinic. The keloids were photographed and assessed with Patient and Observer Scar Assessment Scale (POSAS). Results: Of the 138 keloids, 90 (65%) were clinically in remission. Local side effects, including atrophy of the skin or the subdermal fat, telangiectasia and cortisone traces, occurred in 55% of the cases. The number of injections did not correlate with remission rate or the occurrence of local side effect. ROC curve analysis showed that surface area >620 mm2 was a prognostic factor for not responding to TAC treatment. Conclusion: According to this study, intralesional TAC injections seem to be effective in the treatment of small keloids but not in larger than 620 mm2. Local side effects were more frequent than previously reported and occurred even after just 1 injection. The side effects seem to be permanent in nature.

Keywords

Share This Page

Additional Info

Loading
Loading Please wait..
 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords